Neurology 2017-08-07T17:59:56+00:00


Specialized patient populations that require unique or complex therapies will continue to make neurology the target for dynamic research and commercial markets. With a specific focus on the Multiple Sclerosis (MS) market in the US and the EU, Spherix is shedding light on the key dynamic issues in this fast moving category. The increased risk tolerance and the expanding number of therapies in multiple sclerosis is evolving the treatment strategies for all forms of MS.


Click the links below to download report overviews